TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/04/2026
Voltar para busca
Dado oficial do USPTO
NUCLISENS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
NUCLISENS
ST13
US500000079047682Classe
1, 5, 9, 10
Pedido
79047682
Registro
3746886
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
61
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
03/12/2007
Data de registro
09/02/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/01/2020
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
MARCY L'ETOILE, FR
Examinador
HELLMAN, ELI J
Unidade examinadora
M30
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
bioMérieux
bioMérieux
Representantes
Martin M. Zoltick Rothwell, Figg, Ernst & Manbeck, PC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations and reagents for scientific or research use in laboratories
Classe 5
Diagnostic preparations and reagents for medical and/or clinical purposes
Classe 9
Scientific analysis apparatus for manual and automated testing in industrial applicationsanalysis of industrial samplescosmetic samples and environmental samples to determine contaminants and compositionthe foregoing for quality control purposes and not for medical purposesimmuno analyzersnucleic acid analyzersbacteriologic analyzersmicrobiologic analyzerscomputer and diagnostic apparatus for testing cosmeticsindustrial samples and environmental samples for composition and contaminants; apparatus and instruments for the detection and amplification of nucleic acid in a clinical and/or industrial samplecomputers and diagnostic apparatus for testing cosmeticsindustrial samples and environmental samples for composition and contaminants; computer software for processing and interpreting the results of tests in the field of diagnosis
Classe 10
Medical apparatus and instruments for extracting nucleic acid for diagnosis purposesnucleic acid sequence based amplification system comprised primarily of automated units for isolatingamplifying and/or for detecting nucleic acid; medical diagnostic apparatus for manual and/or automated testing in medical and clinical applicationsdiagnostic apparatus for clinical diagnosis and for medical diagnosis
Publicações
Histórico de despachos e eventos da marca no USPTO.
61 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/04/2026
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
01/04/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/04/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/04/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/04/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/04/2026
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
07/01/2020
71AG
REGISTERED-SEC.71 ACCEPTED
07/01/2020
ES71
TEAS SECTION 71 RECEIVED
16/12/2019
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
09/02/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
21/12/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/08/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/07/2017
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
01/02/2016
C75A
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
01/02/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/02/2016
ES75
TEAS SECTION 71 & 15 RECEIVED
14/01/2016
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/02/2015
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/05/2013
NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/01/2012
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/08/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/08/2011
FICS
FINAL DISPOSITION NOTICE SENT TO IB
27/05/2010
FIMP
FINAL DISPOSITION PROCESSED
27/05/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/05/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
09/02/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/11/2009
PUBO
PUBLISHED FOR OPPOSITION
24/11/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
20/10/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2009
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2009
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/10/2009
GNEA
EXAMINERS AMENDMENT E-MAILED
06/10/2009
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/06/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/06/2009
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/06/2009
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
20/06/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/06/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/06/2009
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/06/2009
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/06/2009
CNFR
FINAL REFUSAL MAILED
06/01/2009
CNFR
FINAL REFUSAL WRITTEN
05/01/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/12/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/12/2008
ALIE
ASSIGNED TO LIE
18/12/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/12/2008
PETG
PETITION TO REVIVE-GRANTED
05/12/2008
PROA
TEAS PETITION TO REVIVE RECEIVED
05/12/2008
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
09/10/2008
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
09/10/2008
RFNT
REFUSAL PROCESSED BY IB
03/04/2008
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/03/2008
RFRR
REFUSAL PROCESSED BY MPU
13/03/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/03/2008
CNRT
NON-FINAL ACTION WRITTEN
12/03/2008
DOCK
ASSIGNED TO EXAMINER
03/03/2008
NWAP
NEW APPLICATION ENTERED
07/01/2008
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/01/2008
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NUCLISENS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.